Video Experimental Relacionado
Updated: May 9, 2025
06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
5.0K
Desbloquear el GAL3: el papel inesperado de la ubiquitina
Ye Zhao1, Kai W Wucherpfennig2
1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Cell
|May 2, 2025
Resumen
El receptor inhibidor LAG3
Área de la Ciencia:
- Inmunología
- Biología molecular
- Investigación del cáncer
Sus antecedentes:
- El receptor inhibidor LAG3 (gen de activación de linfocitos 3) juega un papel en la regulación inmune.
- Comprender el mecanismo de señalización de LAG3 es crucial para desarrollar inmunoterapias efectivas contra el cáncer.
- Relatlimab, un anticuerpo monoclonal (mAb) aprobado por la FDA, se dirige a LAG3, pero su mecanismo preciso sigue sin estar claro.
Objetivo del estudio:
- Para aclarar el mecanismo de señalización del receptor inhibidor LAG3.
- Investigar el papel de la ubiquitinación en la función inhibidora de LAG3.
- Identificar posibles biomarcadores para la respuesta clínica a la inhibición de LAG3.
Principales métodos:
- Ensayos de coinmunoprecipitación para el estudio de las interacciones proteicas.
- La mancha occidental para detectar la ubiquitinación.
- Análisis de los datos de los pacientes para correlacionar la expresión de biomarcadores con la respuesta clínica.
Principales resultados:
- La ubiquitinación del dominio citoplasmático de LAG3 es esencial para su función inhibidora.
- Se identificó la coexpresión de las ligasas LAG3 y CBL E3.
- Esta coexpresión sirve como biomarcador para la respuesta clínica a la inhibición de LAG3 en el melanoma humano.
Conclusiones:
- La ubiquitinación es una modificación post-traduccional clave que regula la señalización inhibidora de LAG3.
- La coexpresión de las ligasas LAG3 y CBL E3 es un biomarcador predictivo de la eficacia del tratamiento anti-LAG3 en el melanoma.
- Este hallazgo hace avanzar nuestra comprensión del papel de LAG3 en la inmunidad contra el cáncer e informa sobre futuras estrategias terapéuticas.
Videos de Conceptos Relacionados
02:58Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
02:04Covalently Linked Protein Regulators
6.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.6K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
01:13The Proteasome
776
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
776
01:23Regulation of Expression at Multiple Steps
843
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
843
01:37The Unfolded Protein Response
4.3K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.3K